Regulation of the procoagulant response to arterial injury

Thrombosis and Haemostasis

Volumn 82, Issue 2, 1999, Pages 801-805

  Taubman, Mark B ^a,b   Giesen, Peter L A ^b   Schecter, Alison D ^a   Nemerson, Yale ^b  

^a Zena and Michael A Wiener Cardiovascular Institute   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

STREPTOKINASE; THROMBOPLASTIN; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ACUTE HEART INFARCTION; ARTERY INJURY; ARTERY INTIMA PROLIFERATION; ARTERY WALL; ATHEROSCLEROTIC PLAQUE; BLOOD CLOTTING; CELL SURFACE; CONFERENCE PAPER; CORONARY ARTERY BYPASS SURGERY; FIBRINOLYSIS; HUMAN; LEUKOCYTE; MACROPHAGE; MONOCYTE; NEUTROPHIL; PRIORITY JOURNAL; REVASCULARIZATION; THROMBOGENESIS; THROMBOSIS;

EID: 0032699236     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1615914     Document Type: Conference Paper

References (54)

1. I. Losordo DW, Rosenfield K, Pieczek A, Baker K, Harding M, Isner JM. How does angioplasty work? Serial analysis of human iliac arteries using intravascular ultrasound. Circulation. 1992;86:1845-1858.
2. Carrozza JP Jr., Baim DS. Complications of directional coronary atherectomy: incidence, causes, and management. Am J Cardiol. 1993;72:47E-54E.
3. Nath FC, Muller DW, Ellis SG, Rosenschein U, Chapekis A, Quain L, Zimmerman, Topol EJ. Thrombosis of a flexible coil coronary stent: frequency, predictors and clinical outcome. J Am Coll Cardiol. 1993;21:622-627.
4. Steele PM, Chesebro JH, Stanson AW, Holmes DR Jr., Dewanjee MK, Badimon L, Fuster V. Balloon angioplasty. Natural history of the pathophysiological response to injury in a pig model. Circ Res. 1985;57:105-112.
5. Stemerman BM. Thrombogenesis of the rabbit arterial plaque. Am J Pathol. 1973;73:7-26.
6. Clowes AW, Reidy MA, Clowes MM. Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium. Lab Invest. 1983;49:327-333.
7. Groves MH, Rathbone-Kinlough LR, Richardson M, Jorgensen L, Moore S, Mustard FJ. Thrombin generation and fibrin formation following injury to rabbit neointima. Lab Invest. 1982;46:605-612.
8. Richardson M, Rathbone-Kinlough LR, Groves MH, Jorgensen LG, Mustard FJ, Moore S. Ultrastructural changes in re-endothelialized and non-endothelialized rabbit aortic neo-intima following re-injury with a balloon catheter. Br J Exp Path. 1984;65.
9. Heras M, Chesebro JH, Penny WJ, Bailey KR, Badimon L, Fuster V. Effects of thrombin inhibition on the development of acute platelet-thrombus deposition during angioplasty in pigs. Heparin versus recombinant hirudin, a specific thrombin inhibitor. Circulation. 1989;79:657-665.
10. Asada Y, Hara S, Tsuneyoshi A, Hatakeyama K, Kisanuki A, Marutsuka K, Sato Y, Kamikubo Y, Sumiyoshi A. Fibrin-rich and platelet-rich thrombus formation on neointima: recombinant tissue factor pathway inhibitor prevents fibrin formation and neointimal development following repeated balloon injury of rabbit aorta. Thromb Haemost. 1998;80:506-511.
11. Nemerson Y. Tissue factor: then and now. Thromb Haemost. 1995;74:180-184.
12. Edgington TS, Mackman N, Brand K, Ruf W. The structural biology of expression and function of tissue factor. Thromb Haemost. 1991;66:67-79.
13. Wilcox JN, Smith KM, Schwartz SM, Gordon D. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci USA. 1989;86:2839-843.
14. Thiruvikraman SV, Guha A, Roboz J, Taubman MB, Nemerson Y, Fallon JT. In situ localization of tissue factor in human atherosclerotic plaques by binding of digoxigenin-labeled factors Vila and X. Lab Invest. 1996;75:451-461.
15. Marmur JD, Thiruvikraman SV, Fyfe BS, Guha A, Sharma SK, Ambrose JA, Fallon JT, Nemerson Y, Taubman MB. Identification of active tissue factor in human coronary atheroma. Circulation. 1996;94:1226-1232.
16. Annex BH, Denning SM, Channon KM, Sketch MH Jr., Stack RS, Morrissey JH, Peters KG. Differential expression of tissue factor protein in directional atherectomy specimens from patients with stable and unstable coronary syndromes. Circulation. 1995;91:619-622.
17. Hatakeyama K, Asada Y, Marutsuka K, Sato Y, Kamikubo Y, Sumiyoshi A. Localization and activity of tissue factor in human aortic atherosclerotic lesions. Atherosclerosis. 1997;133:213-219.
18. Davies MJ, Thomas AC. Plaque fissuring - the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. Br Heart J. 1985;53:363-373.
19. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes (2). N Engl J Med. 1992;326:310-318.
20. Drake AT, Morrissey HJ, Edgington ST. Selective cellular expression of tissue factor in human tissues. Am J Pathol. 1989;134:1087-1097.
21. Marmur JD, Rossikhina M, Guha A, Fyfe B, Friedrich V, Mendlowitz M, Nemerson Y, Taubman MB. Tissue factor is rapidly induced in arterial smooth muscle after balloon injury. J Clin Invest. 1993;91:2253-2259.
22. Pawashe AB, Golino P, Ambrosio G, Migliaccio F, Ragni M, Pascucci I, Chiariello M, Bach R, Garen A, Konigsberg WK, et al. A monoclonal antibody against rabbit tissue factor inhibits thrombus formation in stenotic injured rabbit carotid arteries. Circ Res. 1994;74:56-63.
23. Speidel CM, Eisenberg PR, Ruf W, Edgington TS, Abendschein DR. Tissue factor mediates prolonged procoagulant activity on the luminal surface of balloon-injured aortas in rabbits. Circulation. 1995;92:3323-3330.
24. Speidel CM, Thornton JD, Meng YY, Eisenberg PR, Edgington TS, Abendschein DR. Procoagulant activity on injured arteries and associated thrombi is mediated primarily by the complex of tissue factor and factor VIIa. Coron Artery Dis. 1996;7:57-62.
25. Gallo R, Fallon JT, Toschi V, Gertz SD, Padurean A, Nemerson Y, Chesebro J, Fuster V, Badimon JJ. Bi-phasic increase of tissue factor activity after angioplasty in porcine coronary arteries. Circulation. 1995;92:I-354 (Abstract).
26. Schecter AD, Fallon JT, Thiruvikraman SV, Taby O, Rosenfield CL, Rossikhina M, Nemerson Y, Taubman MB. Delayed surface expression of active tissue factor in human arterial smooth muscle cells determined by a novel in situ activity assay. Circulation. 1995;92:I-804.
27. Bach RR, Moldow CF. Mechanism of tissue factor activation on HL-60 cells. Blood. 1997;89:3270-3276.
28. Carson SD. Manifestation of cryptic fibroblast tissue factor occurs at detergent concentrations which dissolve the plasma membrane. Blood Coagul Fibrinolysis. 1996;7:303-313.
29. Drake TA, Ruf W, Morrissey JH, Edgington TS. Functional tissue factor is entirely cell surface expressed on lipopolysaccharide-stimulated human blood monocytes and a constitutively tissue factor-producing neoplastic cell line. J Cell Biol. 1989;109:389-395.
30. Le DT, Rapaport SI, Rao LV. Relations between factor Vila binding and expression of factor Vila/tissue factor catalytic activity on cell surfaces. J Biol Chem. 1992;267:15447-15454.
31. Maynard JR, Heckman CA, Pitlick FA, Nemerson Y. Association of tissue factor activity with the surface of cultured cells. J Clin Invest. 1975;55:814-824.
32. Mulder AB, Smit JW, Bom VJ, Blom NR, Ruiters MH, Halie MR, van der Meer J. Association of smooth muscle cell tissue factor with caveolae. Blood. 1996;88:1306-1313.
33. Schecter AD, Giesen PL, Taby O, Rosenfield CL, Rossikhina M, Fyfe BS, Kohtz DS, Fallon JT, Nemerson Y, Taubman MB. Tissue factor expression in human arterial smooth muscle cells. TF is present in three cellular pools after growth factor stimulation. J Clin Invest. 1997;100:2276-2285.
34. Fukuda C, lijima K, Nakamura K. Measuring tissue factor (factor III) activity in plasma. Clin Chem. 1989;35:1897-1900.
35. Key NS, Slungaard A, Dandelet L, Nelson SC, Moertel C, Styles LA, Kuypers FA, Bach RR. Whole blood tissue factor procoagulant activity is elevated in patients with sickle cell disease. Blood. 1998;91:4216-4223.
36. Suefuji H, Ogawa H, Yasue H, Kaikita K, Soejima H, Motoyama T, Mizuno Y, Oshima S, Saito T, Tsuji I, Kumeda K, Kamikubo Y, Nakamura S. Increased plasma tissue factor levels in acute myocardial infarction. Am Heart J. 1997;134:253-259.
37. Giesen PL, Rauch U, Bohrmann B, Kling D, Himber J, Roque M, Fallon JT, Badimon JJ, Himber J, Riederer MA, Nemerson Y. Blood-borne tissue factor: a new view of thrombosis. Proc Natl Acad Sci USA. 1999;96:2311-2315.
38. Mackman N. Regulation of tissue factor gene expression in human monocytic and endothelial cells. Haemostasis. 1996;26:17-19.
39. Schecter AD, Rollins BJ, Zhang YJ, Charo IF, Fallon JT, Rossikhina M, Giesen PL, Nemerson Y, Taubman MB. Tissue factor is induced by monocyte chemoattractant protein-1 in human aortic smooth muscle and THP-1 cells. J Biol Chem. 1997;272:28568-28573.
40. Taubman MB, Marmur JD, Rosenfield CL, Guha A, Nichtberger S, Nemerson Y. Agonist-mediated tissue factor expression in cultured vascular smooth muscle cells. Role of Ca2+ mobilization and protein kinase C activation. J Clin Invest. 1993;91:547-552.
41. Schecter SD, Giesen PLA, Fallon JT, Nemerson Y, Taubman MB. PDGF induces the release of active tissue factor (TF) from smooth muscle cells: a potential source of extracellular TF in the atherosclerotic plaque. Circulation. 1997;96:I-43A.
42. Kagawa H, Komiyama Y, Nakamura S, Miyake T, Miyazaki Y, Hamamoto K, Masuda M, Takahashi H, Nomura S, Fukuhara S. Expression of functional tissue factor on small vesicles of lipopolysaccharide-stimulated human vascular endothelial cells [In Process Citation]. Thromb Res. 1998;91:297-304.
43. Schwartz SM, Heimark RL, Majesky MW. Developmental mechanisms underlying pathology of arteries. Physiol Rev. 1990;70:1177-1209.
44. McNamara CA, Sarembock JJ, Bachhuber BG, Stouffer GA, Ragosta M, Barry W, Gimple LW, Powers ER, Owens GK. Thrombin and vascular smooth muscle cell proliferation: implications for atherosclerosis and restenosis. Semin Thromb Hemost. 1996;22:139-144.
45. Ko FN, Yang YC, Huang SC, Ou JT. Coagulation factor Xa stimulates platelet-derived growth factor release and mitogenesis in cultured vascular smooth muscle cells of rat. J Clin Invest. 1996;98:1493-1501.
46. Gasic GP, Arenas CP, Gasic TB, Gasic GJ. Coagulation factors X, Xa, and protein S as potent mitogens of cultured aortic smooth muscle cells. Proc Natl Acad Sci USA. 1992;89:2317-2320.
47. Jang IK, Gold HK, Leinbach RC, Fallon JT, Collen D, Wilcox JN. Antithrombotic effect of a monoclonal antibody against tissue factor in a rabbit model of platelet-mediated arterial thrombosis. Arterioscler Thromb. 1992;12:948-954.
48. Golino P, Ragni M, Cirillo P, D'Andrea D, Scognamiglio A, Ravera A, Buono C, Ezban M, Corcione N, Vigorito F, Condorelli M, Chiariello M. Antithrombotic effects of recombinant human, active site-blocked factor VIIa in a rabbit model of recurrent arterial thrombosis. Circ Res. 1998;82:39-46.
49. Jang Y, Guzman LA, Lincoff AM, Gottsauner-Wolf M, Forudi F, Hart CE, Courtman DW, Ezban M, Ellis SG, Topol EJ. Influence of blockade at specific levels of the coagulation cascade on restenosis in a rabbit atherosclerotic femoral artery injury model. Circulation. 1995;92:3041-3050.
50. Harker LA, Hanson SR, Wilcox JN, Kelly AB. Antithrombotic and antilesion benefits without hemorrhagic risks by inhibiting tissue factor pathway. Haemostasis. 1996;26(suppl. 1):76-82.
51. Oltrona L, Speidel CM, Recchia D, Wickline SA, Eisenberg PR, Abendschein DR. Inhibition of tissue factor-mediated coagulation markedly attenuates stenosis after balloon-induced arterial injury in minipigs. Circulation. 1997;96:646-652.
52. Marder VJ. Thrombolytic therapy: overview of results in major vascular occlusions. Thromb Haemost. 1995;74:101-105.
53. Caplice NM, Mueske CS, Kleppe LS, Simari RD. Presence of tissue factor pathway inhibitor in human atherosclerotic plaques is associated with reduced tissue factor activity. Circulation. 1998;98:1051-1057.
54. Drew AF, Davenport P, Apostolopoulos J, Tipping PG. Tissue factor pathway inhibitor expression in atherosclerosis. Lab Invest. 1997;77:291-298.